Clinical Trial Update: ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis [Phase 2]

View source ↗

Summary

A Phase 2 trial (ABBA CORD) evaluating donor-derived cord blood T cells with abatacept for prophylaxis of acute graft-versus-host disease in patients undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Lymphoma
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Leland Metheny | Conditions: Acute Myelogenous Leukemia, Acute Lymphatic Leukemia | Phase 2 | Status: RECRUITING